These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25699276)

  • 1. Label-free quantitative mass spectrometry reveals a panel of differentially expressed proteins in colorectal cancer.
    Fan NJ; Gao JL; Liu Y; Song W; Zhang ZY; Gao CF
    Biomed Res Int; 2015; 2015():365068. PubMed ID: 25699276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
    Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
    Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
    Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
    J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
    Bai Y; Wang J; Gao Z; Dai E
    Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression analysis of leucine-rich PPR-motif-containing protein (LRPPRC), a candidate colorectal cancer biomarker identified by shotgun proteomics using iTRAQ.
    Nishio T; Kurabe N; Goto-Inoue N; Nakamura T; Sugimura H; Setou M; Maekawa M
    Clin Chim Acta; 2017 Aug; 471():276-282. PubMed ID: 28622966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
    Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.
    Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ
    J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry.
    Kang UB; Yeom J; Kim HJ; Kim H; Lee C
    J Proteomics; 2012 Jun; 75(10):3050-62. PubMed ID: 22154799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
    Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
    Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100P, a calcium-binding protein, is preferentially associated with the growth of polypoid tumors in colorectal cancer.
    Chiang JM; Tan R; Wang JY; Chen JS; Lee YS; Hsieh PS; Changchien CR; Chen JR
    Int J Mol Med; 2015 Mar; 35(3):675-83. PubMed ID: 25585623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
    Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
    J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially expressed proteins of normal and cancerous human colorectal tissues by liquid chromatograph-mass spectrometer based on iTRAQ approach.
    Lv J; Fan N; Wang Y; Wang X; Gao C
    Cancer Invest; 2015; 33(9):420-8. PubMed ID: 26180943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Two Novel CIL-102 Upregulations of ERP29 and FUMH to Inhibit the Migration and Invasiveness of Colorectal Cancer Cells by Using the Proteomic Approach.
    Cheng KC; Kuo HC; Hsieh MC; Huang CY; Teng CC; Tung SY; Shen CH; Lee KF; Yang YL; Lee KC
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colorectal cancer 2D-proteomics: identification of altered protein expression].
    Krasnov GS; Oparina NIu; Khankin SL; Mashkova TD; Ershov AN; Zatsepina OG; Karpov VL; Beresten' SF
    Mol Biol (Mosk); 2009; 43(2):348-56. PubMed ID: 19425502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.
    Chen Y; Xie Y; Xu L; Zhan S; Xiao Y; Gao Y; Wu B; Ge W
    Int J Cancer; 2017 Feb; 140(4):900-913. PubMed ID: 27813080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
    Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
    Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.